Table 2 Clinical characteristics of each ADF patient
Case | Age | Chief complaint | Shock at presentation | Hemoglobin at presentation (g/dL) | Body temperature (℃) | WBC (/μL) | CRP (mg/dL) | History of treatment for any aortic pathology | Comorbidities | Antithrombotic drug NSAIDs | No. of blood transfusions | Type of endoscope used for diagnosis | Use of tip attachment | Shock during endoscopy |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 60 s | Black stool/syncope | None | 6.8 | 36.2 | 4900 | 1.33 | AAA burst EVAR (9 years prior) | CKD | None | 4 | PCF-PQ260L | Yes | None |
2 | 70 s | Black stool | None | 7.2 | 36 | 9100 | 0.4 | AAA EVAR (1 year prior) | None | None | 4 | GIF-Q260J | None | None |
3 | 70 s | Vomiting | Yes | 7.6 | 36.1 | 13,300 | 0.19 | AAA vascular prosthesis replacement (3 years prior) | Angina CKD on HD | Aspirin ticlopidine | 6 | GIF-Q260J | None | None |
4 | 70 s | Vomiting | None | 7.5 | 35.5 | 7100 | 0.14 | Dissecting aortic aneurysm TEVAR + vascular prosthesis replacement (2 years prior) | Angina CKD | Aspirin | 10 | GIF-Q260J | Yes | Yes → expired |
5 | 40 s | Vomiting | Yes | 5.6 | 35.3 | 17,400 | 9.11 | Para-aortic lymph node irradiation (2 years prior) | Cervical cancer | Loxoprofen | 8 | GIF-Q260J | Yes | None |
6 | 70 s | Black stool | None | 9.4 | 36.6 | 11,200 | 1.06 | AAA vascular prosthesis replacement (13 years prior) | CKD | None | 8 | GIF-Q260J | None | None |
7 | 70 s | Black stool | None | 6.4 | 37.3 | 15,500 | 14.9 | AAA EVAR (5 years prior) | CKD Prostate cancer | None | 6 | GIF-Q260J | Yes | None |
8 | 70 s | Black stool/weaknes | None | 6.2 | 37.1 | 8000 | 7.94 | AAA vascular prosthesis replacement (7 months prior) | Myocardial infarction | None | 14 | PCF-PQ260L | Yes | Yes |